Use of TNFα inhibitor

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9512216
APP PUB NO 20160272704A1
SERIAL NO

15173191

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention describes methods of treating erosive polyarthritis comprising administering a TNFα antibody, or antigen-binding portion thereof. The invention also describes a method for testing the efficacy of a TNFα antibody, or antigen-binding portion thereof, for the treatment of erosive polyarthritis.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ABBVIE BIOTECHNOLOGY LTDTHISTLE HOUSE 4 BURNABY STREET HAMILTON HM11

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Chartash, Elliot K Marietta, US 37 1813
Granneman, George R Marco Island, US 16 488
Hoffman, Rebecca S Wilmette, US 58 3572
Taylor, Lori K Boston, US 39 2120
Weinberg, Mark Northbrook, US 17 480
Yan, Philip Vernon Hills, US 39 2227

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jun 6, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00